AEON

AEON Biopharma, Inc.

1.07

USD

AEON Earnings Reports

Positive Surprise Ratio

AEON beat 5 of 7 last estimates.

71%

Next Report

Date of Next Report

Estimate for Q-- -- (Revenue/ EPS)

Implied change from Q3 25 (Revenue/ EPS)

Implied change from Q-- -1 (Revenue/ EPS)

AEON Biopharma, Inc. earnings per share and revenue

On Nov 14, 2025, AEON reported earnings of -0.19 USD per share (EPS) for Q3 25, beating the estimate of -0.43 USD, resulting in a 56.68% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a -3.77% price change (close before vs. close after earnings).

Looking ahead to -- --, -- analysts forecast an EPS of -- USD, with revenue projected to reach -- USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.

FAQ

What were AEON Biopharma, Inc.'s earnings and revenue for the latest quarter Q3 2025?

For Q3 2025, AEON Biopharma, Inc. reported EPS of -$0.19, beating estimates by 56.68%, and revenue of $0.00, 0% as expectations.

How did the market react to AEON Biopharma, Inc.'s Q3 2025 earnings?

The stock price moved down -3.77%, changed from $0.94 before the earnings release to $0.90 the day after.

When is AEON Biopharma, Inc. expected to report next?

The next earning report is scheduled for --.

What are the forecasts for AEON Biopharma, Inc.'s next earnings report?

Based on -- analysts, AEON Biopharma, Inc. is expected to report EPS of -- and revenue of -- for Q-- --.

Which companies are reporting earnings today?

Check FXEmpire's Earnings Calendar for today's list of reporting companies.